4-80184069-G-T
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NR_183912.1(PRDM8-AS1):n.794-645C>A variant causes a intron, non coding transcript change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.127 in 152,758 control chromosomes in the GnomAD database, including 2,016 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.13 ( 2008 hom., cov: 32)
Exomes 𝑓: 0.094 ( 8 hom. )
Consequence
PRDM8-AS1
NR_183912.1 intron, non_coding_transcript
NR_183912.1 intron, non_coding_transcript
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.00300
Genes affected
PRDM8-AS1 (HGNC:55581): (PRDM8 antisense RNA 1)
PRDM8 (HGNC:13993): (PR/SET domain 8) This gene encodes a protein that belongs to a conserved family of histone methyltransferases that predominantly act as negative regulators of transcription. The encoded protein contains an N-terminal Su(var)3-9, Enhancer-of-zeste, and Trithorax (SET) domain and a double zinc-finger domain. Knockout of this gene in mouse results in mistargeting by neurons of the dorsal telencephalon, abnormal itch-like behavior, and impaired differentiation of rod bipolar cells. In humans, the protein has been shown to interact with the phosphatase laforin and the ubiquitin ligase malin, which regulate glycogen construction in the cytoplasm. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 4-80184069-G-T is Benign according to our data. Variant chr4-80184069-G-T is described in ClinVar as [Benign]. Clinvar id is 3256813.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.543 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRDM8-AS1 | NR_183912.1 | n.794-645C>A | intron_variant, non_coding_transcript_variant | |||||
PRDM8-AS1 | NR_183911.1 | n.797-645C>A | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PRDM8-AS1 | ENST00000653209.1 | n.892-645C>A | intron_variant, non_coding_transcript_variant | |||||||
PRDM8-AS1 | ENST00000503589.1 | n.422-645C>A | intron_variant, non_coding_transcript_variant | 4 | ||||||
PRDM8 | ENST00000508965.5 | n.177+14G>T | intron_variant, non_coding_transcript_variant | 3 | ||||||
PRDM8 | ENST00000509375.5 | n.175+14G>T | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.127 AC: 19333AN: 152096Hom.: 2003 Cov.: 32
GnomAD3 genomes
AF:
AC:
19333
AN:
152096
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0938 AC: 51AN: 544Hom.: 8 Cov.: 0 AF XY: 0.0990 AC XY: 41AN XY: 414
GnomAD4 exome
AF:
AC:
51
AN:
544
Hom.:
Cov.:
0
AF XY:
AC XY:
41
AN XY:
414
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.127 AC: 19360AN: 152214Hom.: 2008 Cov.: 32 AF XY: 0.137 AC XY: 10212AN XY: 74436
GnomAD4 genome
AF:
AC:
19360
AN:
152214
Hom.:
Cov.:
32
AF XY:
AC XY:
10212
AN XY:
74436
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1464
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Jul 31, 2024 | This variant is classified as Benign based on local population frequency. This variant was detected in 37% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy, Progressive Myoclonus Epilepsy and Abnormal Movements and Neurodegeneration with brain iron accumulation. Number of patients: 34. Only high quality variants are reported. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at